Abstract

Breaking a bottleneck for on-target toxicity: A mutant-selective PI3K�� inhibitor finally comes

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call